Osteopathic Manipulation Therapy in the Treatment of Interstitial Cystitis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00873171|
Recruitment Status : Completed
First Posted : April 1, 2009
Last Update Posted : April 16, 2010
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||24 participants|
|Observational Model:||Case Control|
|Official Title:||Osteopathic Manipulation Therapy in the Treatment of Interstitial Cystitis|
|Study Start Date :||January 2009|
|Actual Primary Completion Date :||November 2009|
|Actual Study Completion Date :||November 2009|
This procedure consist of Sacral rocking is performed by placing the heel of the practitioner's hand over the sacrum and by using the palpatory skills of an osteopathic physician; rock the sacrum into a position with no restriction. Myofascial release will utilize various physical motions to place the patients lumbosacral region in a position of maximal comfort and tissue release.
2. Attention control OMT
The procedure consist of light pressure applied to certain painful areas of the body and back to decrease pain and help patient relax. The physician will look for areas of the body that hurt, lay his/her hands on the those places, and apply light pressure.
3. Standard of Care
This procedure consists of various conservative treatments that can help reduce stress. Those include dietary modifications, pharmaceuticals, bladder training, and neuromodulation. If these treatments are not successful, minimally invasive surgical procedures is performed.
- Effectiveness of Osteopathic Manipulation therapy over standard of care invasive procedures for the treatment of interstitial cystitis. [ Time Frame: Within 2 weeks of treatment ]
- To determine if the increased attention and power of touch are as effective as OMT in treating patients with IC based on the results of using attention control treatment in some patients. [ Time Frame: Within 2 weeks of treatment ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00873171
|United States, West Virginia|
|James P. Tierney D.O.|
|Charleston, West Virginia, United States, 25304|
|Principal Investigator:||James P Tierney, D.O.||CAMC Medical Staff - with admitting privileges|